Waiver of In Vivo Bioavailability and Bioequivalence ...

Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. Guidance for Industry . U.S. Department of Health and Human Services Food and Drug Administration . Center for Drug Evaluation and Research (CDER) December 2017 . Biopharmaceutics

  Studies, Bioequivalence, Bioavailability, Bioavailability and bioequivalence, Bioavailability and bioequivalence studies